Foghorn Therapeutics Inc. Expense Breakdown
No Expense Breakdown for FHTX on this site yet.
- 2026-06-30: The $200.00K.
- 2025-06-30: The $900.00K.
Source checked: the stored Expense Breakdown page for FHTX.
Expenses by product
Depreciation, Depletion and Amortization: each quarter (3 month)
| Quarter end | The |
|---|---|
| 2026-06-30 | $200.00K |
| 2025-06-30 | $900.00K |
Other General And Administrative Expense: each quarter (3 month)
| Quarter end | The |
|---|---|
| 2026-06-30 | $1.57M |
| 2025-06-30 | $1.94M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |